Johnson & Johnson (JNJ)
undefined
undefined%
At close: undefined
143.89
0.34%
Pre-market Jan 07, 2025, 06:45 AM EST

Company Description

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide.

The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR.

CI:LABO, NEUTROGENA, and OGX brands; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products.

It also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand.

It serves general public, retail outlets, and distributors.

The company's Pharmaceutical segment offers products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS and COVID-19 infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes and macular degeneration; and pulmonary arterial hypertension.

This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use.

Its MedTech segment provides electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand.

This segment serves wholesalers, hospitals, and retailers.

The company was founded in 1886 and is based in New Brunswick, New Jersey.

Johnson & Johnson
Johnson & Johnson logo
Country United States
IPO Date Jan 2, 1943
Industry Drug Manufacturers - General
Sector Healthcare
Employees 131,900
CEO Joaquin Duato

Contact Details

Address:
One Johnson & Johnson Plaza
New Brunswick, New Jersey
United States
Website https://www.jnj.com

Stock Details

Ticker Symbol JNJ
Exchange NYSE
Fiscal Year February - January
Reporting Currency USD
CIK Code 0000200406
CUSIP Number 478160104
ISIN Number US4781601046
Employer ID 22-1024240
SIC Code 2834

Key Executives

Name Position
Joaquin Duato Chief Executive Officer & Chairman
Elizabeth Forminard J.D. Executive Vice President & Chief Legal Officer
James Swanson Executive Vice President & Chief Information Officer
Joseph J. Wolk CPA Executive Vice President & Chief Financial Officer
Dirk Brinckman Chief Compliance Officer
Dr. Guy J. Lebeau M.D. Group Chairman of MD&D Business - EMEA
Dr. John C. Reed M.D., Ph.D. Executive Vice President of Innovative Medicine, R&D
Jennifer L. Taubert Executive Vice President & Worldwide Chairman of Innovative Medicine
Jessica Moore Vice President of Investor Relations
Robert J. Decker Jr. Controller & Chief Accounting Officer

Latest SEC Filings

Date Type Title
Dec 12, 2024 4 Filing
Dec 12, 2024 4 Filing
Dec 12, 2024 4 Filing
Nov 13, 2024 13F-HR Quarterly report filed by institutional managers, ...
Nov 06, 2024 25-NSE Filing
Nov 01, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Oct 31, 2024 4/A [Amend] Filing
Oct 23, 2024 10-Q Quarterly Report
Oct 21, 2024 4 Filing
Oct 18, 2024 SC 13G Statement of acquisition of beneficial ownership b...